首页> 外文OA文献 >Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans.

【2h】

Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans.

机译：CD4 + T细胞应答对人类口服野生型肠毒素大肠杆菌后临床结果的影响。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Monica A McArthur; Wilbur H Chen; Laurence Magder; Myron M Levine; Marcelo B Sztein;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans [J] . Monica A. McArthur, Wilbur H. Chen, Laurence Magder, PLOS Neglected Tropical Diseases . 2017,第1期

机译：口服人类野生型肠毒素大肠杆菌后CD4 + T细胞反应对临床结果的影响
2. A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea dose optimization, clinical outcomes, and CD4+ T cell responses [J] . Sunniva Todnem Sakkestad, Hans Steinsland, Steinar Skrede, PLOS Neglected Tropical Diseases . 2019,第10期

机译：一种新的人类挑战模型，用于测试基于热稳定毒素的疫苗候选物的产肠毒素性大肠杆菌腹泻剂量优化，临床结果和CD4 + T细胞反应
3. Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers [J] . Subhra Chakraborty, Clayton Harro, Barbara DeNearing, PLOS Neglected Tropical Diseases . 2018,第4期

机译：较低剂量的产肠毒素大肠杆菌对成人志愿者的临床结局，肠道定植和免疫反应的影响
4. Possibility of oral immunization of piglets against enterotoxigenic strains of Escherichia coli post weaning with colonizing factor F4 [C] . M. Zizlavsky, P. Alexa, J. Hamrik Congress of the International Pig Veterinary Society . 1999

机译：用殖民因子F4断奶术后大肠杆菌的肠毒素菌株口服免疫仔猪的可能性
5. Characterization of Enterotoxigenic Escherichia coli Isolates of Varying Clinical Presentations using Comparative Genomics and Transcriptomics. [D] . Sistrunk, Jeticia R. 2017

机译：使用比较基因组学和转录组学对多种临床表现的产肠毒素大肠杆菌分离株进行表征。
6. Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans [O] . Monica A. McArthur, Wilbur H. Chen, Laurence Magder, 2017

机译：口服野生型肠毒素大肠杆菌后CD4 + T细胞反应对临床结果的影响
7. A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea – dose optimization, clinical outcomes, and CD4+ T cell responses [O] . Sunniva Todnem Sakkestad, Hans Steinsland, Steinar Skrede, 2019

机译：一种新的人体挑战模型，用于测试肠毒素大肠杆菌腹泻剂量优化，临床结果和CD4 + T细胞反应的肠毒素基毒素候选患者
8. Immunologic Control by Oral Vaccines of Diarrheal Disease Due to Enterotoxigenic Escherichia coli and Shigella [R] . Levine, M. M. 1988

机译：产肠毒素大肠杆菌和志贺氏菌引起的腹泻病口服疫苗免疫控制

Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans.

著录项

引文网络

相似文献

相关主题

期刊订阅